BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32619424)

  • 1. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.
    Venturutti L; Teater M; Zhai A; Chadburn A; Babiker L; Kim D; Béguelin W; Lee TC; Kim Y; Chin CR; Yewdell WT; Raught B; Phillip JM; Jiang Y; Staudt LM; Green MR; Chaudhuri J; Elemento O; Farinha P; Weng AP; Nissen MD; Steidl C; Morin RD; Scott DW; Privé GG; Melnick AM
    Cell; 2020 Jul; 182(2):297-316.e27. PubMed ID: 32619424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.
    Jiang Y; Ortega-Molina A; Geng H; Ying HY; Hatzi K; Parsa S; McNally D; Wang L; Doane AS; Agirre X; Teater M; Meydan C; Li Z; Poloway D; Wang S; Ennishi D; Scott DW; Stengel KR; Kranz JE; Holson E; Sharma S; Young JW; Chu CS; Roeder RG; Shaknovich R; Hiebert SW; Gascoyne RD; Tam W; Elemento O; Wendel HG; Melnick AM
    Cancer Discov; 2017 Jan; 7(1):38-53. PubMed ID: 27733359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis.
    Béguelin W; Teater M; Gearhart MD; Calvo Fernández MT; Goldstein RL; Cárdenas MG; Hatzi K; Rosen M; Shen H; Corcoran CM; Hamline MY; Gascoyne RD; Levine RL; Abdel-Wahab O; Licht JD; Shaknovich R; Elemento O; Bardwell VJ; Melnick AM
    Cancer Cell; 2016 Aug; 30(2):197-213. PubMed ID: 27505670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Culture of Mouse Primary B Lymphocytes by Forced Expression of
    Finney J; Kelsoe G
    J Immunol; 2021 Sep; 207(5):1478-1492. PubMed ID: 34389622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring
    Mansoor A; Akhter A; Hamidi M; Roshan TM; Shabani-Rad MT; Stewart D
    Anticancer Res; 2023 Nov; 43(11):4801-4807. PubMed ID: 37909960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes.
    Rivas MA; Durmaz C; Kloetgen A; Chin CR; Chen Z; Bhinder B; Koren A; Viny AD; Scharer CD; Boss JM; Elemento O; Mason CE; Melnick AM
    Front Immunol; 2021; 12():688493. PubMed ID: 34621263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.
    Franco R; Scognamiglio G; Valentino E; Vitiello M; Luciano A; Palma G; Arra C; La Mantia E; Panico L; Tenneriello V; Pinto A; Frigeri F; Capobianco G; Botti G; Cerchia L; De Chiara A; Fedele M
    Oncotarget; 2016 Sep; 7(37):59158-59172. PubMed ID: 27494852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.
    Jones CL; Bhatla T; Blum R; Wang J; Paugh SW; Wen X; Bourgeois W; Bitterman DS; Raetz EA; Morrison DJ; Teachey DT; Evans WE; Garabedian MJ; Carroll WL
    J Biol Chem; 2014 Jul; 289(30):20502-15. PubMed ID: 24895125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.
    Ding BB; Yu JJ; Yu RY; Mendez LM; Shaknovich R; Zhang Y; Cattoretti G; Ye BH
    Blood; 2008 Feb; 111(3):1515-23. PubMed ID: 17951530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type.
    El Jamal SM; Grada Z; El Dinali MH; Zhou H; Hassan SY; Saad AG; Gibson B; Zhou X; Abulsayen HA; Khadra HS; Friedman J; Shalaby H; Kadi A; Megahed M; Emberesh M; Teruya-Feldstein J; Firpo-Betancourt A; Haikel Y; Fraig M; Hassan M
    Lab Invest; 2019 Apr; 99(4):539-550. PubMed ID: 30446717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.
    Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
    Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific mutation in TBL1XR1 causes Pierpont syndrome.
    Heinen CA; Jongejan A; Watson PJ; Redeker B; Boelen A; Boudzovitch-Surovtseva O; Forzano F; Hordijk R; Kelley R; Olney AH; Pierpont ME; Schaefer GB; Stewart F; van Trotsenburg AS; Fliers E; Schwabe JW; Hennekam RC
    J Med Genet; 2016 May; 53(5):330-7. PubMed ID: 26769062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
    Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
    Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAD4 plays a critical role in germinal center response by regulating Bcl-6 and NF-κB activation.
    Gao F; Yang Y; Wang Z; Gao X; Zheng B
    Cell Immunol; 2015 Mar; 294(1):1-8. PubMed ID: 25656449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity of Card11 mutant and Bcl6 in the development of diffuse large B-cell lymphoma in a mouse model.
    Takahara T; Matsuo K; Seto M; Nakamura S; Tsuzuki S
    Cancer Sci; 2016 Nov; 107(11):1572-1580. PubMed ID: 27560392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pierpont syndrome associated with the p.Tyr446Cys missense mutation in TBL1XR1.
    Slavotinek A; Pua H; Hodoglugil U; Abadie J; Shieh J; Van Ziffle J; Kvale M; Lee H; Kwok PY; Risch N; Sabbadini M
    Eur J Med Genet; 2017 Oct; 60(10):504-508. PubMed ID: 28687524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaiso is a key regulator of spleen germinal center formation by repressing Bcl6 expression in splenocytes.
    Koh DI; Yoon JH; Kim MK; An H; Kim MY; Hur MW
    Biochem Biophys Res Commun; 2013 Dec; 442(3-4):177-82. PubMed ID: 24269670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.
    Jaye DL; Iqbal J; Fujita N; Geigerman CM; Li S; Karanam S; Fu K; Weisenburger DD; Chan WC; Moreno CS; Wade PA
    J Pathol; 2007 Sep; 213(1):106-15. PubMed ID: 17573669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TBLR1 regulates the expression of nuclear hormone receptor co-repressors.
    Zhang XM; Chang Q; Zeng L; Gu J; Brown S; Basch RS
    BMC Cell Biol; 2006 Aug; 7():31. PubMed ID: 16893456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.